...

AmiKana.BioLogics

Visitez le site officiel

A propos de l'employeur

AmiKana.BioLogics is a privately held biotech company incorporated in December 2007. It operates from laboratory space in the La Timone Faculty of Medicine in Marseille, France. Our goal is to improve the clinical management of patients failing therapy by providing tools for drug resistance analysis using the yeast cell. The implementation of AmiKana’s tools will allow optimization of personalized medicine and improve drug development. AmiKana.BioLogics holds exclusive rights, on patent protected methods, to market the tools it develops.

THE YEAST CELL AS A CELLULAR READER OF DRUG RESISTANCE PHENOMENA

Drug resistance, the result of specific mutations in drug targets and/or related target proteins, leads to lack of response to therapy. While protein sequencing, in search of resistance-conferring mutations, is an appropriate approach when the repertoire is known, functional analysis is required for unknown mutation repertoires. The drug resistance functional analyses on the market are complex and require either an appropriate laboratory for cell culture and/or a certified Level 3 containment facility. AmiKana.BioLogics develops a new variety of biological tools for implementation in microbiology laboratories, using the yeast cell as a cellular reader of drug resistance. These tools analyze drug resistances in a cellular, reproducible, user-friendly, easy-to-read, and low-cost system. AmiKana.BioLogics’ first product addresses both HIV resistance diagnostics/treatment optimization, and services to pharmaceutical companies targeting viral infectious diseases.

Clinical Partners

AmiKana.BioLogics has signed partnership agreements, for the implementation of clinical studies related to HIV and HCV diagnostic tools, with the:

  • Virology Laboratory (Laboratoire de virology), La Timone Hospital, Marseille, France, headed by Pr Didier Raoult.
  • Infectious Diseases Department (Service d’infectiologie), Nice University Hospital, France, headed by Pr. Pierre Dellamonica.
  • Fundacion HUESPED, Buenos Aires Argentina, chaired by Dr Pedro Cah, head of Infectious Diseases Unit at Hospital Juan A. Fernandez of Buenos Aires.

Localisation de l'employeur

Découvrez des employeurs similaires

...
University of Luxembourg Luxembourg 102 offres disponibles
...
KU Leuven Louvain, Belgique 89 offres disponibles
...
Ghent University Gand, Belgique 69 offres disponibles
...
ETH Zürich Zurich, Suisse 61 offres disponibles
...
University of Twente Enschede, Pays-Bas 59 offres disponibles
Plus d'employeurs

Cela pourrait vous intéresser

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min de lecture
...
The genetic detectives discovering who we really are University of Turku 5 min de lecture
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min de lecture
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min de lecture
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min de lecture
Plus de stories

Découvrez les offres d'emplois similaires